Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States – 2008–2012

Abstract Background Prevention of pre-invasive cervical lesions is an important benefit of HPV vaccines, but demonstrating impact on these lesions is impeded by changes in cervical cancer screening. Monitoring vaccine-types associated with lesions can help distinguish vaccine impact from screening e...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Vaccine 2015-03, Vol.33 (13), p.1608-1613
Hauptverfasser:	Hariri, Susan, Bennett, Nancy M, Niccolai, Linda M, Schafer, Sean, Park, Ina U, Bloch, Karen C, Unger, Elizabeth R, Whitney, Erin, Julian, Pamela, Scahill, Mary W, Abdullah, Nasreen, Levine, Diane, Johnson, Michelle L, Steinau, Martin, Markowitz, Lauri E
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma in Situ - diagnosis Adenocarcinoma in Situ - prevention & control Adenocarcinoma in Situ - virology Adult Allergy and Immunology California Catchment areas Cervical cancer Cervical intraepithelial neoplasia Cervical Intraepithelial Neoplasia - diagnosis Cervical Intraepithelial Neoplasia - prevention & control Cervical Intraepithelial Neoplasia - virology CIN Connecticut Early Detection of Cancer Female High grade cervical lesion HPV Human papillomavirus Human papillomavirus 16 - isolation & purification Human papillomavirus 18 - isolation & purification Humans Immunization Laboratories Lesions New York Oregon Papillomavirus Vaccines - administration & dosage Papillomavirus Vaccines - therapeutic use Prevalence Prevention Sentinel Surveillance Tennessee Time Factors United States Uterine Cervical Diseases - prevention & control Vaccination Vaccine Vaccines Womens health Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!